Effects of N-acetylcysteine and tirilazad mesylate on intestinal functional capillary density, leukocyte adherence, mesenteric plasma extravasation and cytokine levels in experimental endotoxemia in rats

Clinical Hemorheology and Microcirculation

Volumn 39, Issue 1-4, 2008, Pages 99-111

  Birnbaum, J ^a   Lehmann, Ch ^b   Klotz, E ^a   Hein, O Vargas ^a   Blume, A ^a   Jubin, F ^a   Polze, N ^a   Luther, D ^a   Spies, C D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Cytokines; Endotoxin; Extravasation; Intestine; Intravital microscopy; Mesentery; NAC; Perfusion; Rat; Sepsis; Tirilazad mesylate

Indexed keywords

ACETYLCYSTEINE; ENDOTOXIN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; MALONALDEHYDE; TIRILAZAD; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CAPILLARY DENSITY; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTOXEMIA; FLUORESCENCE MICROSCOPY; INTESTINE FUNCTION; INTESTINE MUCOSA; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE COUNT; MALE; NONHUMAN; RAT; SEPSIS;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CAPILLARIES; CELL ADHESION; CYTOKINES; ENDOTOXEMIA; ENDOTOXINS; HEART RATE; INTESTINES; LEUKOCYTES; MALE; PREGNATRIENES; RATS; RATS, WISTAR;

EID: 47849093867     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1073     Document Type: Conference Paper

References (28)

1. T. Sordia, J. Tatarishvili and G. Mchedlishvili, Hemorheological disorders in the microcirculation during septic shock in rats, Clin. Hemorheol. Microcirc. 35 (2006), 223-226.
2. R.S. Hotchkiss and I.E. Karl, The pathophysiology and treatment of sepsis, N. Engl. J. Med. 348 (2003), 138-150.
3. D.M. Radomska-Lesniewska, A.M. Sadowska, F.J. Van Overveld, U. Demkow, J. Zielinski and W.A. De Backer, Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells, J. Physiol. Pharmacol. 57(Suppl. 4) (2006), 325-334.
4. R.M. Faruqi, E.J. Poptic, T.R. Faruqi, M.C. De La and P.E. DiCorleto, Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression, Am. J. Physiol. 273 (1997), H817-H826.
5. H. Schmidt, W. Schmidt, T. Muller, H. Bohrer, M.M. Gebhard and E. Martin, N-acetylcysteine attenuates endotoxin-induced leukocyte-endothelial cell adhesion and macromolecular leakage in vivo, Crit. Care Med. 25 (1997), 858-863.
6. W. Schmidt, A. Walther, M.M. Gebhard, E. Martin and H. Schmidt, Influence of N-acetylcysteine treatment on endotoxin-induced microcirculatory disturbances, Intens. Care Med. 24 (1998), 967-972.
7. J. Ruh, E. Schmidt and F. Vogel, Effect of N-acetylcysteine on microcirculation of mucosa in rat ileum in a model of intestinal inflammation, Dig. Dis. Sci. 48 (2003), 882-889.
8. C. Spies, I. Witt, C. Walensky, L. Hannemann and K. Reinhart, Influence of N-Acetylcysteine on O(2) consumption and gastric intramucosal Ph in septic patients, Br. J. Anaesth. 70 (1993), 97.
9. O.V. Hein, R. Ohring, A. Schilling, M. Oellerich, V.W. Armstrong, W.J. Kox and C. Spies, N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report, Crit. Care 8 (2004), R66-R71.
10. C.D. Spies, K. Reinhart, I. Witt, A. Meier-Hellmann, L. Hannemann, D.L. Bredle and W. Schaffartzik, Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients - Results from A prospective, randomized, double-blind-study, Crit. Care Med. 22 (1994), 1738-1746.
11. L. Del Sorbo and H. Zhang, Is there a place for N-acetylcysteine in the treatment of septic shock?, Crit. Care 8 (2004), 93-95.
12. H. Spapen, N-acetylcysteine in clinical sepsis: a difficult marriage, Crit. Care 8 (2004), 229-230.
13. M.C. Atkinson, The use of N-acetylcysteine in intensive care, Crit. Care Res. 4 (2002), 21-27.
14. H.D. Spapen, M.W. Diltoer, D.N. Nguyen, I. Hendrickx and L.P. Huyghens, Effects of N-acetylcysteine on microalbuminuria and organ failure in acute severe sepsis: results of a pilot study, Chest 127 (2005), 1413-1419.
15. H. Spapen, H. Zhang and J.L. Vincent, Potential therapeutic value of lazaroids in endotoxemia and other forms of sepsis, Shock 8 (1997), 321-327.
16. P. Liu, S.L. Vonderfecht, G.M. McGuire, M.A. Fisher, A. Farhood and H. Jaeschke, The 21-aminosteroid tirilazad mesylate protects against endotoxin shock and acute liver failure in rats, J. Pharmacol. Exp. Ther. 271 (1994), 438-445.
17. H. Zhang, H. Spapen, P. Manikis, P. Rogiers, G. Metz, W.A. Buurman and J.L. Vincent, Tirilazad mesylate (U-74006F) inhibits effects of endotoxin in dogs, Am. J. Physiol. 268 (1995), H1847-H1855.
18. R.R. Eversole, S.L. Smith, L.J. Beuving and E.D. Hall, Protective effect of the 21-aminosteroid lipid peroxidation inhibitor tirilazad mesylate (U74006F) on hepatic endothelium in experimental hemorrhagic shock, Circ. Shock 40 (1993), 125-131.
19. N.F. Kassell, E.C. Haley, Jr., C. Apperson-Hansen and W.M. Alves, Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand, J. Neurosurg. 84 (1996), 221-228.
20. S.H. Wong, J.A. Knight, S.M. Hopfer, O. Zaharia, C.N. Leach, Jr. and F.W. Sunderman, Jr., Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct, Clin. Chem. 33 (1987), 214-220.
21. B. Leithauser, M. Fassbender, M. Eickhoff, M. Elg, G. Eichner and F.R. Matthias, The direct thrombin inhibitor melagatran counteracts endotoxin-induced endothelial leukocyte adherence and microvascular leakage in the rat mesentery. Rationale for the treatment of inflammatory disorders beyond sepsis?, Clin. Hemorheol. Microcirc. 36 (2007), 277-289.
22. J. Birnbaum, E. Klotz, C.D. Spies, B. Lorenz, P. Stuebs, O.V. Hein, M. Grundling, D. Pavlovic, T. Usichenko, M. Wendt, W.J. Kox and C. Lehmann, Effects of dopexamine on the intestinal microvascular blood flow and leukocyte activation in a sepsis model in rats, Crit. Care 10 (2006), R117.
23. C. Lehmann, A. Georgiew, M. Weber, J. Birnbaum and W.J. Kox, Reduction in intestinal leukocyte adherence in rat experimental endotoxemia by treatment with the 21-aminosteroid U-74389G, Intens. Care Med. 27 (2001), 258-263.
24. K. Ley, Leukocyte adhesion to vascular endothelium, J. Reconstr. Microsurg. 8 (1992), 495-503.
25. H. Zhang, H. Spapen, D.N. Nguyen, M. Benlabed, W.A. Buurman and J.L. Vincent, Protective effects of N-acetyl-L-cysteine in endotoxemia, Am. J. Physiol. 266 (1994), H1746-H1754.
26. H. Spapen, H. Zhang, C. Demanet, W. Vleminckx, J.L. Vincent and L. Huyghens, Does N-acetyl-L-cysteine influence cytokine response during early human septic shock? Chest 113 (1998), 1616-1624.
27. S.D. Semrad, M.L. Rose and J.L. Adams, Effect of tirilazad mesylate (U74006F) on eicosanoid and tumor necrosis factor generation in healthy and endotoxemic neonatal calves, Circ. Shock 40 (1993), 235-242.
28. T. Volk, M. Schmutzler, L. Engelhardt, W.D. Docke, H.D. Volk, W. Konertz and W.J. Kox, Influence of aminosteroid and glucocorticoid treatment on inflammation and immune function during cardiopulmonary bypass, Crit. Care Med. 29 (2001), 2137-2142.